VL Surveyor
Discover the first interactive online tool that displays the details of visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL) clinical trials across geographic locations and time.
VL Surveyor in Wellcome Open Research
Peer-reviewed publication on IDDO's VL living systematic review
VL Surveyor Methodology
The visceral leishmaniasis (VL) Surveyor maps all the relevant registered and published VL clinical trials looking at efficacy of pharmaceuticals, conducted globally to date. Created in 2016, the Surveyor includes data derived from a systematic review (Bush JT, Wasunna M, Alves F, Alvar J, Olliaro PL, Otieno M, et al. (2017) Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLoS Negl Trop Dis 11(9): e0005781) conducted in the same year. In addition to the data from this systematic review, the Surveyor is regularly updated with details of newly-registered and published trials.
The following clinical trials registries and publication repositories were queried for all registered VL trials to date:
- clinicaltrials.gov
- WHO International Clinical Trials Registry Platform (ICTRP)
- The Cochrane Library
- PubMed
To conform to current systematic review best practice, all update searches from January 2016 forward were expanded to include results from these additional repositories.
- Embase
- Scopus
- Global Index Medicus
- IMEMR
- IMSEAR
- LILACS
- Web of Science
- Publications and trials describing studies on cutaneous leishmaniasis, post kala-azar dermal leishmaniasis (PKDL), canine VL, vector control, nets, prevalence estimation, diagnostic tests, vaccines or prophylaxis were excluded.
- Non-intervention studies, case reports, retrospective studies and individual studies enrolling fewer than six patients were also excluded.
- No restriction was placed on the date or language.
- Screening was performed using Covidence systematic review software (covidence.org)
- Each trial is represented by a pin on the map corresponding to the study site. Each pin can be clicked to produce a pop-up box, which presents more information about the trial. Within the pop-up boxes there are links to the publications which link directly to PubMed. The pins are coloured according to the status of the trial (e.g. published, completed, active, withdrawn, unknown and terminated). The information for the unpublished trials has been obtained from the respective clinical trial registries.
- The filters on the left-hand side can be enabled to restrict the trials according to their status, the drugs used, the country they were conducted in, the diagnostic method used, the inclusion of participants with HIV co-infection and the trial design.
- Below the map, there are further filters that allow the user to explore the trials performed at specific time periods and restrict according to the number of patients enrolled in trials.
- The “Get the data” button downloads a spreadsheet containing all the data presented on the VL Surveyor along with an open database license agreement.
- This is a fast-evolving field of research and therefore the rules and filters will be adapted to reflect new information as it is received.
((((((((randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR clinical trials as topic[mesh:noexp] OR randomly[tiab] OR trial[ti] NOT (animals[mh] NOT humans [mh]))) AND Clinical Trial[ptyp])) AND (((("Leishmaniasis, Visceral"[Mesh]) OR visceral leishmaniasis[Title/Abstract]) OR kala azar[Title/Abstract]) OR black fever[Title/Abstract]))) OR ((((((((((((((("Pentamidine"[Mesh]) OR "liposomal amphotericin B" [Supplementary Concept]) OR "Amphotericin B"[Mesh]) OR "Paromomycin"[Mesh]) OR "miltefosine" [Supplementary Concept]) OR "Sodium"[Mesh]) OR "8-aminoquinoline" [Supplementary Concept]) OR "Ketoconazole"[Mesh]) OR "Azoles"[Mesh]) OR "Allopurinol"[Mesh]) OR ( "Atovaquone"[Mesh] OR "atovaquone, proguanil drug combination" [Supplementary Concept] ))) OR ((pentamidine[Title/Abstract] OR ambisome[Title/Abstract] OR amphotericin[Title/Abstract] OR paromomycin[Title/Abstract] OR miltefosine[Title/Abstract] OR pentavalent[Title/Abstract] OR sodium[Title/Abstract] OR sitamaquine[Title/Abstract] OR azole*[Title/Abstract] OR allopurinol[Title/Abstract] OR atovaquone[Title/Abstract] OR ketoconazole[Title/Abstract] OR fluconazole[Title/Abstract] OR metronidazole[Title/Abstract])))) AND (((("Leishmaniasis, Visceral"[Mesh]) OR visceral leishmaniasis[Title/Abstract]) OR kala azar[Title/Abstract]) OR black fever[Title/Abstract])))) NOT (((animals not humans))) This search strategy uses the PubMed RCT filter for sensitivity- and precision-maximising version (2008). https://work.cochrane.org/pubmed
- exp visceral leishmaniasis/ (9032)
- "black fever".ti,ab. (16)
- "kala azar".ti,ab. (2138)
- "visceral leishmaniasis".ti,ab. (8713)
- 1 or 2 or 3 or 4 (11608)
- exp randomized controlled trial/ (546363)
- Controlled clinical study/ (461844)
- Random$.ti,ab. (1401563)
- randomization/ (82089)
- intermethod comparison/ (246778)
- placebo.ti,ab. (286120)
- (compare or compared or comparison).ti. (477335)
- ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab. (1903401)
- (open adj label).ti,ab. (70475)
- ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. (217393)
- double blind procedure/ (159727)
- parallel group$1.ti,ab. (23261)
- (crossover or cross over).ti,ab. (97631)
- ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab. (302405)
- (assigned or allocated).ti,ab. (355650)
- (controlled adj7 (study or design or trial)).ti,ab. (316500)
- (volunteer or volunteers).ti,ab. (233422)
- trial.ti. (267888)
- 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 (4285150)
- 5 and 24 (1387)
- (pentamidine or ambisome or amphotericin or paromomycin or miltefosine or pentavalent or sodium or sitamaquine or azole* or allopurinol or atovaquone or ketoconazole or fluconazole or metronidazole).mp. (957377)
- 5 and 26 (3490)
- 25 or 27 (4481)
- (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.) (6108726)
- 30 28 not 29 (3496) This search strategy uses the Cochrane RCT filter for Embase. https://www.cochranelibrary.com/central/central‐creation
( ( TITLE-ABS-KEY ( "visceral leishmaniasis" OR "kala azar" OR "black fever" ) ) AND ( ( TITLE-ABS-KEY ( random* OR rct OR placebo OR allocat* OR crossover* OR "cross over" OR trial OR ( doubl* W/1 blind* ) OR ( singl* W/1 blind* ) ) ) OR ( TITLE-ABS-KEY ( control* W/1 trial* ) ) OR ( TITLE-ABS-KEY ( cohort* ) ) ) ) OR ( ( TITLE-ABS-KEY ( "visceral leishmaniasis" OR "kala azar" OR "black fever" ) ) AND ( TITLE ABS-KEY ( pentamidine OR ambisome OR amphotericin OR paromomycin OR miltefosine OR pentavalent OR sodium OR sitamaquine OR azole* OR allopurinol OR atovaquone OR ketoconazole OR fluconazole OR metronidazole ) ) ) AND ( EXCLUDE ( EXACTKEYWORD , "Animals" ) OR EXCLUDE ( EXACTKEYWORD , "Animal" ) OR EXCLUDE ( EXACTKEYWORD , "Animal Experiment" ) OR EXCLUDE ( EXACTKEYWORD , "Mouse" ) OR EXCLUDE ( EXACTKEYWORD , "Mice" ) OR EXCLUDE ( EXACTKEYWORD , "Dogs" ) )
- TOPIC: ("visceral leishmaniasis" OR "kala azar" OR "black fever")
- TOPIC: (random* OR rct OR placebo OR allocat* OR crossover* OR "cross over" OR trial OR (doubl* near/1 blind*) OR (singl* near/1 blind*))
- TOPIC: (control* near/1 trial*)
- TOPIC: (cohort*)
- #4 OR #3 OR #2
- #5 AND #1
- TOPIC: (pentamidine OR ambisome OR amphotericin OR paromomycin OR miltefosine OR pentavalent OR sodium OR sitamaquine OR azole* OR allopurinol OR atovaquone OR ketoconazole OR fluconazole OR metronidazole)
- #7 AND #1
- #8 OR #6
- #8 OR #6
- MeSH descriptor: [Leishmaniasis, Visceral] explode all trees 144
- "visceral leishmaniasis" 230
- "kala azar" 113
- "black fever" 1 #5 #1 or #2 or #3 or #4 276
World Health Organization Global Index Medicus http://www.globalhealthlibrary.net/php/index.php?lang=en
tw:(tw:(("visceral leishmaniasis" OR "kala azar" OR "black fever") ) AND (instance:"ghl")
ClinicalTrials.gov Advanced Search https://clinicaltrials.gov/ct2/search/advanced?
Condition or disease: visceral leishmaniasis OR kala azar OR black fever
WHO International Clinical Trials Registry Platform http://apps.who.int/trialsearch/ visceral leishmaniasis OR kala azar OR black fever – Trials at ALL stages
The searches were divided into four stages:
- Clinical trial registries clinicaltrials.gov and ICTRP were queried with the search terms ‘visceral leishmaniasis’ and ‘kala azar’.
- PubMed was searched using the search term ‘Visceral Leishmaniasis’ and applying the ‘article type’ filter ‘clinical trial’.
- A broader search of PubMed (for the updates, Embase, Scopus, and Web of Science were also searched) was conducted using the query ‘((kala AND azar) OR (visceral AND leishmaniasis)) AND (pentamidine OR ambisome OR amphotericin OR paromomycin OR miltefosine OR pentavalent OR sodium)’.
- The Cochrane library was searched using the search term ‘Visceral Leishmaniasis’ and applying the ‘article type’ filter ‘clinical trial’.
further details: Bush JT, Wasunna M, Alves F, Alvar J, Olliaro PL, Otieno M, et al. (2017) Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLoS Negl Trop Dis 11(9): e0005781